Cisplatin therapy does not worsen renal function in severe antenatal Bartter syndrome Journal Article


Authors: Welch, T. R.; Shaffer, D. R.; Feldman, D. R.
Article Title: Cisplatin therapy does not worsen renal function in severe antenatal Bartter syndrome
Abstract: A 30-year-old man with severe antenatal Bartter syndrome, diagnosed and treated in infancy, developed testicular carcinoma. Despite the known renal complications of cisplatin, this drug was used for his chemotherapy because of its superior antineoplastic effect. Nonsteroidal anti-inflammatory drug administration was continued during cisplatin therapy. Despite an increase in his oral potassium requirement, renal function was maintained following completion of chemotherapy. In spite of its significant associated nephrotoxicity, cisplatin can be used in patients with severe antenatal Bartter syndrome if required for therapy of malignancy. © 2017 2017 The Author(s).
Keywords: cisplatin; chemotherapy; testicular cancer; bartter syndrome
Journal Title: Case Reports in Nephrology and Dialysis
Volume: 7
Issue: 2
ISSN: 2296-9705
Publisher: Karger  
Date Published: 2017-05-01
Start Page: 49
End Page: 54
Language: English
DOI: 10.1159/000475838
PROVIDER: scopus
PMCID: PMC5465520
PUBMED: 28612006
DOI/URL:
Notes: Article -- Export Date: 4 October 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Darren Richard Feldman
    340 Feldman